Market Cap (In KRW)
503.81 Billion
Revenue (In KRW)
263.23 Billion
Net Income (In KRW)
-10.58 Billion
Avg. Volume
600.81 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 17610.0-39100.0
- PE
- -
- EPS
- -
- Beta Value
- -0.228136
- ISIN
- KR7064550007
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Han-Oh Park
- Employee Count
- -
- Website
- https://www.bioneer.co.kr
- Ipo Date
- 2005-12-29
- Details
- Bioneer Corporation engages in the biotechnology research products, molecular diagnosis, drugs, and probiotics businesses in South Korea. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide functional analysis, and magnetic separation services, as well as instruments for conventional PCR, real-time PCR, sample preparation, protein synthesis, centrifuge and vortex mixer, electrophoresis, spectrophotometer, and microbial culture. It also provides molecular diagnosis, including MDx technologies, human diagnostics kits, MDx extraction kits, and instruments; and products for animal diseases and nano-bio products. The company was founded in 1992 and is headquartered in Daejeon, South Korea.
More Stocks
-
EVGIF
-
002821
-
GATEWAYGateway Distriparks Limited
GATEWAY
-
YONXFYONEX Co., Ltd.
YONXF
-
6698
-
603861
-
FTII
-
AROCAroCell AB (publ)
AROC